HIV-1 antibody - Debris or virion?

被引：125

作者：

Parren, PWHI

Burton, DR

Sattentau, QJ

机构：

[1] Scripps Res Inst, DEPT MOL BIOL, LA JOLLA, CA 92037 USA

[2] CTR IMMUNOL MARSEILLE LUMINY, F-13288 MARSEILLE, FRANCE

来源：

NATURE MEDICINE | 1997年 / 3卷 / 04期

关键词：

D O I：

10.1038/nm0497-366d

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：366 / 367

页数：2

共 9 条

[1] MOLECULAR PROFILE OF AN ANTIBODY-RESPONSE TO HIV-1 AS PROBED BY COMBINATORIAL LIBRARIES [J].

BARBAS, CF ;

COLLET, TA ;

AMBERG, W ;

ROBEN, P ;

BINLEY, JM ;

HOEKSTRA, D ;

CABABA, D ;

JONES, TM ;

WILLIAMSON, RA ;

PILKINGTON, GR ;

HAIGWOOD, NL ;

CABEZAS, E ;

SATTERTHWAIT, AC ;

SANZ, I ;

BURTON, DR .

JOURNAL OF MOLECULAR BIOLOGY, 1993, 230 (03) :812-823

[2] PREDETERMINATION BY INFECTION AND BY VACCINATION OF ANTIBODY RESPONSE TO INFLUENZA VIRUS VACCINES [J].

DAVENPORT, FM ;

HENNESSY, AV .

JOURNAL OF EXPERIMENTAL MEDICINE, 1957, 106 (06) :835-850

[3] Mapping the protein surface of human immunodeficiency virus type 1 gp120 using human monoclonal antibodies from phage display libraries [J].

Ditzel, HJ ;

Parren, PWHI ;

Binley, JM ;

Sodroski, J ;

Moore, JP ;

Barbas, CF ;

Burton, DR .

JOURNAL OF MOLECULAR BIOLOGY, 1997, 267 (03) :684-695

[4] Evaluation of monoclonal antibodies to human immunodeficiency virus type 1 primary isolates by neutralization assays: Performance criteria for selecting candidate antibodies for clinical trials [J].

DSouza, MP ;

Livnat, D ;

Bradac, JA ;

Bridges, SH ;

Bryson, Y ;

Hanson, C ;

Matthews, T ;

Moore, J ;

Trkola, A ;

ZollaPazner, S ;

Gorny, M ;

Burton, D ;

Merigan, T ;

McNamara, J ;

Norcross, M ;

Posner, M ;

Robinson, J ;

ViraniKetter, N ;

Barbas, CF ;

Parren, P ;

Katinger, H .

JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (05) :1056-1062

[5] NATIVE OLIGOMERIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN ELICITS DIVERSE MONOCLONAL-ANTIBODY REACTIVITIES [J].

EARL, PL ;

BRODER, CC ;

LONG, D ;

LEE, SA ;

PETERSON, J ;

CHAKRABARTI, S ;

DOMS, RW ;

MOSS, B .

JOURNAL OF VIROLOGY, 1994, 68 (05) :3015-3026

[6] In vitro antigen challenge of human antibody libraries for vaccine evaluation: The human immunodeficiency virus type 1 envelope [J].

Parren, PWHI ;

Fisicaro, P ;

Labrijn, AF ;

Binley, JM ;

Yang, WP ;

Ditzel, HJ ;

Barbas, CF ;

Burton, DR .

JOURNAL OF VIROLOGY, 1996, 70 (12) :9046-9050

[7] RECOGNITION PROPERTIES OF A PANEL OF HUMAN RECOMBINANT FAB FRAGMENTS TO THE CD4 BINDING-SITE OF GP120 THAT SHOW DIFFERING ABILITIES TO NEUTRALIZE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].

ROBEN, P ;

MOORE, JP ;

THALI, M ;

SODROSKI, J ;

BARBAS, CF ;

BURTON, DR .

JOURNAL OF VIROLOGY, 1994, 68 (08) :4821-4828

[8] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEUTRALIZATION IS DETERMINED BY EPITOPE EXPOSURE ON THE GP120 OLIGOMER [J].

SATTENTAU, QJ ;

MOORE, JP .

JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (01) :185-196

[9] BIOSYNTHESIS, CLEAVAGE, AND DEGRADATION OF THE HUMAN IMMUNODEFICIENCY VIRUS-1 ENVELOPE GLYCOPROTEIN-GP160 [J].

WILLEY, RL ;

BONIFACINO, JS ;

POTTS, BJ ;

MARTIN, MA ;

KLAUSNER, RD .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (24) :9580-9584

← 1 →